Phase I trial of hypofractionated chemoradiotherapy in the palliative management of esophageal and gastro-esophageal cancer

- Sridharan, Swetha, Day, Fiona, Loh, Jasmin, Lynam, James, Smart, Joanne, Holt, Brandon, Mandaliya, Hiren, Bonaventura, Anthony, Kumar, Mahesh, Martin, Jarad

Gastrostomy dependency trends over 15 years of patients at a large tertiary referral center following the insertion of a prophylactic gastrostomy for chemoradiation for mucosal head and neck cancer

- Fraser, Allison, Odelli, Cathy, Britton, Ben, Kumar, Mahesh, Day, Fiona, Tieu, Minh Thi, Wratten, Chris

Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial

- Porceddu, Sandro Virgilio, Bressel, Mathias, Collins, Marnie, Collins, Michael Kevin, Macann, Andrew Martin John, Milross, Christopher Gerard, Penniment, Michael Gordon, Liu, Howard Yu-hao, King, Madeleine Trudy, Panizza, Benedict James, Rischin, Danny, Poulsen, Michael Geoffrey, Stoneley, Adam, Veness, Michael John, Kenny, Lizbeth Moira, Wratten, Chris, Corry, June, Cooper, Stephen, Fogarty, Gerald Blaise

The GOFURTGO study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer

- Goldstein, D., Spry, N., Shapiro, J., Porter, I. W. T., Hruby, G., Horvath, L., Bydder, S., Underhill, C., Harvey, J., Gebski, V. J., Cummins, M. M., Brown, C., van Hazel, G. A., Carroll, S., Selva-Nayagam, S., Borg, M., Ackland, S. P., Wratten, C.